Skip to main content
Pediatric NephrologyVolume 21, Issue 1, January 2006, Pages 46-53

Childhood microscopic polyangiitis associated with MPO-ANCA(Article)

  Save all to author list
  • aDepartment of Nephrology, University Children's Hospital, Tirsova 10, 11000 Belgrade, Serbia
  • bInstitute of Allergy and Clinical Immunology, Clinical Centre of Serbia, Belgrade, Serbia
  • cInstitute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia
  • dClinical Centre of Serbia, Institute of Dermatology, Belgrade, Serbia

Abstract

We reviewed the clinical, histological and serological parameters of microscopic polyangiitis (MPA) associated with antineutrophil cytoplasmic antibodies (ANCA) specific to myeloperoxidase (MPO). Six girls and one boy aged 12.0±2.6 years (7-15 years) met the following inclusion criteria: (1) clinical manifestations of systemic small vessel involvement; (2) histological demonstration of pauci-immune necrotizing glomerulonephritis; and (3) serological findings of increased concentration of MPO-ANCA by ELISA test. The main clinical manifestations were: influenza-like symptoms (100%), hematuria/ proteinuria (100%), purpura (100%), pulmonary-renal syndrome (57%), acute renal failure (ARF) (29%), ischemic cerebral insults (29%), and necrotizing vasculitis of the skin (29%). All patients underwent renal biopsy examined by immunohistochemistry with expression of alpha-smooth muscle actin (alpha SMA) in glomerular and interstitial spaces. Patients were followed from 6 months to 5.5 years (35.4±23.2 months). None of the patients died. Two of seven children who had ARF progressed to end stage renal disease; one developed chronic renal failure, and four normalized renal function. ARF and central nervous system involvement at presentation were parameters of poor renal outcome. A high score of fibro-cellular glomerular crescents was associated with worse prognosis. Early treatment enables a favorable prognosis of MPO-ANCA-associated MPA in children. © IPNA 2005.

Author keywords

Acute renal failureAlpha SMAANCAChildhoodMicroscopic polyangiitis

Indexed keywords

EMTREE drug terms:alpha smooth muscle actinazathioprinecorticosteroidcyclophosphamidecyclosporin Ameprednisonemycophenolic acid 2 morpholinoethyl estermyeloperoxidaseneutrophil cytoplasmic antibody
EMTREE medical terms:acute kidney failureadolescentANCA associated vasculitisarticlebrain ischemiachildchronic kidney failureclinical articleclinical featuredisease coursedrug substitutionenzyme linked immunosorbent assayfemaleflu like syndromefollow uphematuriahemodialysishistopathologyhumanimmunohistochemistrykidney biopsykidney functionmalemicroscopic polyangiitisnecrotizing arteritisplasmapheresispriority journalprognosisprotein expressionproteinuriapurpuraretrospective studyserodiagnosis

Chemicals and CAS Registry Numbers:

azathioprine, 446-86-6; cyclophosphamide, 50-18-0; meprednisone, 1247-42-3; myeloperoxidase

  • ISSN: 0931041X
  • CODEN: PEDNE
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1007/s00467-005-2063-x
  • PubMed ID: 16252100
  • Document Type: Article
  • Publisher: Springer Verlag

  Peco-Antic, A.; Department of Nephrology, University Children's Hospital, Tirsova 10, Serbia;
© Copyright 2019 Elsevier B.V., All rights reserved.

Cited by 58 documents

Quezada, N.A. , Ramírez, M.L.
Characterization of primary vasculitis in pediatrics | Caracterización de las vasculitis primarias en pediatría
(2024) Andes Pediatrica
Ozen, S. , Orhan, D. , Marks, S.D.
Renal Vasculitis
(2022) Pediatric Nephrology: Eighth Edition
Sayad, E. , Vogel, T.P. , Guillerman, R.P.
Pulmonary manifestations and outcomes in paediatric ANCA-associated vasculitis: A single-centre experience
(2021) Rheumatology (United Kingdom)
View details of all 58 citations
{"topic":{"name":"ANCA Associated Vasculitis; Neutrophil Cytoplasmic Antibody; Computed Tomography","id":132,"uri":"Topic/132","prominencePercentile":97.8338,"prominencePercentileString":"97.834","overallScholarlyOutput":0},"dig":"259f4499b2cfde830ef1370140c11309a74c852868180e1b307bbd9e6c403769"}

SciVal Topic Prominence

Topic:
Prominence percentile: